Do you have cancer with a MET alteration?
Learn about an investigational drug designed to target the
c-Met pathway and slow tumor growth in the SPARTA study. If you have
non-small cell lung cancer (NSCLC), brain cancer, or another advanced solid tumor, you may qualify.
Learn More
Do I Qualify?